Related Experiment Videos

Conditional risk factors for atherosclerosis

Iftikhar J Kullo1, Christie M Ballantyne

  • 1Department of Internal Medicine and Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA. kullo.iftikhar@mayo.edu

Mayo Clinic Proceedings
|February 12, 2005
PubMed

Insights

Conventional risk factors for coronary heart disease (CHD) have limited accuracy. This review examines conditional risk factors like homocysteine and C-reactive protein to improve CHD risk prediction in asymptomatic individuals.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Atherosclerosis Research

Background:

  • Conventional risk factors for coronary heart disease (CHD) have limited predictive accuracy for atherosclerosis events.
  • Many individuals without CHD events possess conventional risk factors, necessitating improved prediction models.
  • Circulating biomarkers are being investigated to enhance CHD risk stratification.

Purpose of the Study:

  • To review conditional risk factors for CHD prediction in asymptomatic individuals.
  • To update clinicians on the utility of specific biomarkers in assessing cardiovascular risk.
  • To discuss the mechanisms, assays, evidence, and clinical implications of these risk factors.

Main Methods:

  • Literature review of conditional risk factors for CHD.
  • Analysis of biomarkers including homocysteine, fibrinogen, lipoprotein(a), LDL particle size, and C-reactive protein.
  • Evaluation of current clinical availability and utility of these risk factors.

Main Results:

  • Conditional risk factors may refine CHD risk prediction beyond conventional factors.
  • Evidence for association with CHD and clinical implications are discussed for each biomarker.
  • Focus on biomarkers currently available to clinicians for risk assessment.

Conclusions:

  • Conditional risk factors show potential for improving CHD risk prediction in asymptomatic populations.
  • Understanding these biomarkers aids in better cardiovascular risk management.
  • Further evaluation is needed to fully integrate these factors into clinical practice.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...